|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Roche
|
|
gptkbp:acquisitionYear
|
2018
|
|
gptkbp:CEO
|
gptkb:Brian_Alexander
|
|
gptkbp:focus
|
precision medicine
cancer genomics
|
|
gptkbp:founded
|
2010
|
|
gptkbp:founder
|
gptkb:Todd_Golub
gptkb:Eric_S._Lander
gptkb:Michael_J._Pellini
gptkb:Matthew_Meyerson
|
|
gptkbp:headquarters_location
|
gptkb:Cambridge,_Massachusetts,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Foundation Medicine
|
|
gptkbp:industry
|
gptkb:biotechnology
healthcare
|
|
gptkbp:IPODate
|
2013
|
|
gptkbp:listedOn
|
gptkb:NASDAQ
|
|
gptkbp:notableClient
|
oncologists
academic researchers
pharmaceutical companies
|
|
gptkbp:numberOfEmployees
|
1000+
|
|
gptkbp:parentCompany
|
gptkb:Roche
|
|
gptkbp:product
|
gptkb:FoundationACT
gptkb:FoundationOne_CDx
gptkb:FoundationOne_Liquid
|
|
gptkbp:service
|
biomarker discovery
clinical trial matching
comprehensive genomic profiling
companion diagnostics
|
|
gptkbp:stockSymbol
|
gptkb:FMI
|
|
gptkbp:website
|
https://www.foundationmedicine.com/
|
|
gptkbp:bfsParent
|
gptkb:罗氏
|
|
gptkbp:bfsLayer
|
5
|